Your browser doesn't support javascript.
loading
Mechanism and structure based design of inhibitors of AMP and adenosine deaminase.
Lindell, Stephen D; Maechling, Simon; Klein, Robert; Freigang, Jörg; Laber, Bernd; Blanazs, Lisa; Leonhardt, Merisa; Haupt, Susanne; Petry, Thomas; Sabina, Richard L.
Afiliação
  • Lindell SD; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany. Electronic address: lindell@t-online.de.
  • Maechling S; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
  • Klein R; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
  • Freigang J; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
  • Laber B; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
  • Blanazs L; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
  • Leonhardt M; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
  • Haupt S; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
  • Petry T; Bayer AG, Crop Science Division, Industriepark Höchst, 65926 Frankfurt am Main, Germany.
  • Sabina RL; Department of Biomedical Sciences, Oakland University, William Beaumont School of Medicine, Rochester, MI 48309, USA.
Bioorg Med Chem ; 43: 116272, 2021 08 01.
Article em En | MEDLINE | ID: mdl-34157570
ABSTRACT
Inhibitors of the enzyme adenosine monophosphate deaminase (AMPD) show interesting levels of herbicidal activity. An enzyme mechanism-based approach has been used to design new inhibitors of AMPD starting from nebularine (6) and resulting in the synthesis of 2-deoxy isonebularine (16). This compound is a potent inhibitor of the related enzyme adenosine deaminase (ADA; IC50 16 nM), binding over 5000 times more strongly than nebularine. It is proposed that the herbicidal activity of compound 16 is due to 5́-phosphorylation in planta to give an inhibitor of AMPD. Subsequently, an enzyme structure-based approach was used to design new non-ribosyl AMPD inhibitors. The initial lead structure was discovered by in silico screening of a virtual library against plant AMPD. In a second step, binding to AMPD was further optimised via more detailed molecular modeling leading to 2-(benzyloxy)-5-(imidazo[2,1-f][1,2,4]triazin-7-yl)benzoic acid (36) (IC50 300 nM). This compound does not inhibit ADA and shows excellent selectivity for plant over human AMPD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Adenosina Desaminase / Inibidores de Adenosina Desaminase / AMP Desaminase Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Adenosina Desaminase / Inibidores de Adenosina Desaminase / AMP Desaminase Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article